Counterfeit Cancer-fighting Drug Avastin

Pharmaceutical company Roche issues warning about counterfeit cancer-fighting drug Avastin.

"The investigation is ongoing and we are assisting the authorities" in the United States, a spokeswoman for the Swiss firm said.

Colorectal Cancer - Types, Causes, Risk Factors, Symptoms, Diagnosis, Treatment, Prognosis & Prevention
Colorectal cancer is a cancer that starts in the colon or the rectum. Colorectal cancer is the third most common cancer in men.

Genentech, Roche's US subsidiary, warned in a statement, "The counterfeit product is not safe or effective and should not be used.

"Chemical analyses of the counterfeit vials tested to date have confirmed the product does not contain the active ingredients for Avastin."

Some of the counterfeit US lots are believed to be labeled as Avastin 400 mg/16 ml and have the serial numbers B86017, B6011 and B6010.

Quiz on Breast Cancer
Breast cancer is one of the leading causes of cancer deaths among women. It is often said that a woman who breast-feeds is at a lower risk of developing cancer compared to another who does not .Are these mere old wives tales or is there some truth in it? This quiz on breast cancer has all the details.

Genentech said the suspect batches differ from the official product, which is certified by the US Drug Administration (FDA).

Genuine Avastin boxes are normally marked with six digit serial numbers and have no letters, stated the company.

Avastin Stabilizes Tumors in Ovarian Cancer
Avastin (bevacizumab) can stabilize tumors in ovarian cancer, claimed two independent groups working with advanced-stage cases.

Avastin is used to treat colorectal, lung, kidney, breast and ovarian cancer and is among Roche's top-selling drugs with a turnover of 5.3 billion Swiss francs ($5.8 billion, 4.4 billion euros) in 2011.

Source-AFP

Avastin Receives European Approval for Ovarian Cancer Treatment
Roche has revealed that the European Commission has approved the use of Avastin for treating women with early and advanced form of ovarian cancer.